I certainly hope you are right. Maybe I'm reading too much into the tea leaves, but how on earth could a small biotech bleeding cash launch another major trial? Is this new trial a sign that we're close to closing a deal with BP? Wildly optimistic, I now, but just a thought.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.